Skip to main content

Clinician Adherence to Screening and Preventive Practices for Non-Malignant Late Effects Among Allogeneic Hematopoietic Cell Transplant Survivors in the United States

Conferences
Lee, CJ; Hellewell, EM; Ng, K; Gooley, T; Sung, AD; Taylor, AO; Hong, S; Ahmed, N; Morey, C; Fitzmaurice, S; Kennedy, VE; Lauer, M; Trunk, AD ...
Published in: Blood
November 5, 2024

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Blood

DOI

EISSN

1528-0020

ISSN

0006-4971

Publication Date

November 5, 2024

Volume

144

Issue

Supplement 1

Start / End Page

2170 / 2170

Publisher

American Society of Hematology

Related Subject Headings

  • Immunology
  • 3213 Paediatrics
  • 3201 Cardiovascular medicine and haematology
  • 3101 Biochemistry and cell biology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Lee, C. J., Hellewell, E. M., Ng, K., Gooley, T., Sung, A. D., Taylor, A. O., … Bhatt, N. (2024). Clinician Adherence to Screening and Preventive Practices for Non-Malignant Late Effects Among Allogeneic Hematopoietic Cell Transplant Survivors in the United States. In Blood (Vol. 144, pp. 2170–2170). American Society of Hematology. https://doi.org/10.1182/blood-2024-210263
Lee, Catherine J., Elizabeth M. Hellewell, Kevin Ng, Ted Gooley, Anthony D. Sung, Allison O. Taylor, Sanghee Hong, et al. “Clinician Adherence to Screening and Preventive Practices for Non-Malignant Late Effects Among Allogeneic Hematopoietic Cell Transplant Survivors in the United States.” In Blood, 144:2170–2170. American Society of Hematology, 2024. https://doi.org/10.1182/blood-2024-210263.
Lee CJ, Hellewell EM, Ng K, Gooley T, Sung AD, Taylor AO, et al. Clinician Adherence to Screening and Preventive Practices for Non-Malignant Late Effects Among Allogeneic Hematopoietic Cell Transplant Survivors in the United States. In: Blood. American Society of Hematology; 2024. p. 2170–2170.
Lee, Catherine J., et al. “Clinician Adherence to Screening and Preventive Practices for Non-Malignant Late Effects Among Allogeneic Hematopoietic Cell Transplant Survivors in the United States.” Blood, vol. 144, no. Supplement 1, American Society of Hematology, 2024, pp. 2170–2170. Crossref, doi:10.1182/blood-2024-210263.
Lee CJ, Hellewell EM, Ng K, Gooley T, Sung AD, Taylor AO, Hong S, Ahmed N, Morey C, Fitzmaurice S, Kennedy VE, Lauer M, Trunk AD, Hamilton BK, Sharma A, Phelps-Bergeron Z, Hill L, Faramand R, Liu H, Winestone LE, Cheng G, Espinoza-Gutarra M, Jamy O, Odstrcil Bobillo M, McClune B, Nawas MT, Yates SJ, Nishitani M, Takahashi T, Koo J, Myers K, Mahadeo KM, Bauchat A, Pearson LK, Walia R, Seago K, Yingling S, Edgar C, Browning A, Bhatt N. Clinician Adherence to Screening and Preventive Practices for Non-Malignant Late Effects Among Allogeneic Hematopoietic Cell Transplant Survivors in the United States. Blood. American Society of Hematology; 2024. p. 2170–2170.

Published In

Blood

DOI

EISSN

1528-0020

ISSN

0006-4971

Publication Date

November 5, 2024

Volume

144

Issue

Supplement 1

Start / End Page

2170 / 2170

Publisher

American Society of Hematology

Related Subject Headings

  • Immunology
  • 3213 Paediatrics
  • 3201 Cardiovascular medicine and haematology
  • 3101 Biochemistry and cell biology